Latest Artificial pacemaker Stories
WOODCLIFF LAKE, N.J., Jan. 3, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it began shipping the 225mg, 325mg, and 425mg strengths of propafenone SR capsules, the generic version of GlaxoSmithKline's Rythmol SRÂ®.
SANTA CLARA, Calif., Dec. 2, 2010 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that Dr.
Implanted devices that treat cardiac dysfunction in heart failure patients are as successful in â€œreal worldâ€ use as they are in controlled clinical trial settings, according to a large new study reported in Circulation: Journal of the American Heart Association.
KING OF PRUSSIA, Pa., Nov. 18, 2010 /PRNewswire/ -- Prism Pharmaceuticals, Inc. announced today that the U.S.
Scientists studying genetic data from nearly 50,000 people have uncovered several DNA sequence variations associated with the electrical impulses that make the heart beat.
University of Michigan Cardiovascular Center examines logistics of safe, cost-effective pacemaker donation.
In a Canadian first, the Peter Munk Cardiac Centre used a new kind of left ventricular assist device (LVAD) to treat a patient with advanced heart failure.
SHREWSBURY, N.J., Sept. 22 /PRNewswire/ -- Angel Medical Systems announced today that it has received CE (Conformite Europeenne) Mark approval for the commercial sale of The AngelMed Guardian System in Europe.
DALLAS, September 21, 2010 /PRNewswire/ -- ReportsandReports announces it will carry U.S.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.